Kotak Mahindra Mutual Fund acquired up to 45.28 lakh shares (4.19%) for Rs 385 crore at a price of Rs 850.87 apiece.

Trump's threat of 200% tariff on pharmaceutical products could have severe implications on Indian drugmakers, as exports to the US form a significant share of their overall sales.